Effects of a β-blocker on the cardiovascular response to MDMA (Ecstasy)

Emergency Medicine Journal

Volumn 27, Issue 8, 2010, Pages 586-589

  Hysek, C M ^a   Vollenweider, F X ^b   Liechti, M E ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; PINDOLOL; PLACEBO;

ADULT; ANOREXIA; ARTICLE; BALANCE IMPAIRMENT; BODY TEMPERATURE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; TACHYCARDIA; THIRST;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; BODY TEMPERATURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; HEART RATE; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PINDOLOL; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 77955370997     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emj.2009.079905     Document Type: Article

References (27)

1. Hall AP, Henry JA. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth 2006;96:678-85.
2. Liechti ME, Kunz I, Kupferschmidt H. Acute medical problems due to Ecstasy use. Case-series of emergency department visits. Swiss Med Wkly 2005;135:652-7.
3. Qasim A, Townend J, Davies MK. Ecstasy induced acute myocardial infarction. Heart 2001;85:E10.
4. Lai TI, Hwang JJ, Fang CC, et al. Methylene 3, 4 dioxymethamphetamine- induced acute myocardial infarction. Ann Emerg Med 2003;42:759-62.
5. Liechti ME, Gamma A, Vollenweider FX. Gender differences in the subjective effects of MDMA. Psychopharmacology (Berl) 2001;154:161-8.
6. Boehrer JD, Moliterno DJ, Willard JE, et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 1993;94:608-10.
7. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990;112:897-903.
8. Hoffman RS. Cocaine and beta-blockers: should the controversy continue? Ann Emerg Med 2008;51:127-9.
9. Wittchen HN, Pfister H. DIA-X-Interview [program]. D-Frankfurt: Swets Test Services, 1997.
10. Hasler F, Studerus E, Lindner K, et al. Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA J Psychopharmacol 2009;23:923-35.
11. Zerssen DV. Die Beschwerden-Liste. Münchener Informationssystem. München, D: Psychis, 1976.
12. Liechti ME, Vollenweider FX. The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4- methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers. J Psychopharmacol 2000;14:269-74.
13. Liechti ME, Saur MR, Gamma A, et al. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology 2000;23:396-404.
14. Rabiner EA, Gunn RN, Castro ME, et al. Beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy. Neuropsychopharmacology 2000;23:285-93.
15. Callaway CW, Rempel N, Peng RY, et al. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine. Neuropsychopharmacology 1992;7:113-27.
16. Millan MJ, Colpaert FC. Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors. Eur J Pharmacol 1991;193:145-52.
17. Lyon RA, Glennon RA, Titeler M. 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Psychopharmacology (Berl) 1986;88:525-6.
18. Liechti ME, Baumann C, Gamma A, et al. Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 2000; 22:513-21.
19. Ramoska E, Sacchetti AD. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med 1985;14:1112-3.
20. Rappolt RT, Gay GR, Inaba DS. Propranolol: a specific antagonist to cocaine. Clin Toxicol 1977;10:265-71.
21. Sofuoglu M, Brown S, Babb DA, et al. Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug Alcohol Depend 2000;60:69-76. (Pubitemid 30255987)
22. Sofuoglu M, Brown S, Babb DA, et al. Effects of labetalol treatment on the physiological and subjective response to smoked cocaine. Pharmacol Biochem Behav 2000;65:255-9.
23. Freeman K, Feldman JA. Cocaine, myocardial infarction, and beta-blockers: time to rethink the equation? Ann Emerg Med 2008;51:130-4.
24. Liechti ME, Vollenweider FX. Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol 2001;16:589-98.
25. Knuepfer MM. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther 2003;97:181-222.
26. McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008;117:1897-907.
27. Liechti ME. ["Ecstasy" (MDMA): pharmacology, toxicology, and treatment of acute intoxication]. Dtsch Med Wochenschr 2003;128:1361-6.